Ritesh International sets Sept 22 e-voting cut-off for AGM

scanx
Reviewed by
Suketu GScanX News Team
Key Highlights
  • Ritesh International fixes Sept 22, 2026, as the cut-off date for AGM e-voting eligibility
  • E-voting window opens Sept 25 at 9:00 am and closes Sept 27 at 5:00 pm via CDSL
  • AGM scheduled for Sept 28, 2026, with book closure from Sept 23 to Sept 28
  • Agenda includes re-appointment of MD Ritesh Arora and revised pay for Wholetime Director Rijul Arora
  • Company cites FY26 margin drop and demand slowdown impacting managerial remuneration limits
powered bylight_fuzz_icon
49560820

*this image is generated using AI for illustrative purposes only.

Ritesh International has fixed September 22, 2026, as the record date for determining shareholder eligibility for its 44th Annual General Meeting. The e-voting window runs from September 25 to September 27, 2026.

The company scheduled its AGM for September 28, 2026, at 11:00 am at its registered office in Ahmedgarh, Punjab. The register of members and share transfer books will remain closed from September 23 to September 28, 2026.

Key Board Approvals

The board approved the notice for the 44th AGM on August 29, 2026. Key agenda items include:

  • Re-appointment of Mr. Ritesh Arora (DIN: 00080156) as Managing Director.
  • Revision in remuneration payable to Mr. Rijul Arora (DIN: 07477956).
  • Appointment of CA Keshav Madaan as Internal Auditor for FY27.
  • Appointment of M/s Verma Khushwinder & Co. as Cost Auditor for FY27.
  • Appointment of CS Ansh Bhambri as scrutinizer for remote e-voting and the AGM.

Director Remuneration Details

Shareholders will vote on special resolutions regarding director compensation. The explanatory statement notes that profits may not be adequate for calculating limits under managerial remuneration due to a drop in margins and demand slowdown in FY26.

Mr. Ritesh Arora (Managing Director)

  • Term: Five years from December 14, 2026, to December 13, 2031.
  • Salary: ₹5,00,000 per month till March 31, 2027; rising to ₹7,50,000 per month from April 1, 2027, with a 7% annual increment.
  • Perquisites: Includes medical reimbursement, leave travel concession, electricity bill up to ₹50,000 per month, and residential maintenance fee up to ₹15,000 per month.

Mr. Rijul Arora (Wholetime Director)

  • Term: Three years from October 1, 2026, to September 30, 2029.
  • Salary: ₹5,00,000 per month from April 1, 2027, with a 7% annual increment.
  • Perquisites: Includes medical reimbursement, leave travel concession, electricity bill up to ₹25,000 per month, and residential maintenance fee up to ₹10,000 per month.

Auditor Appointments

The board appointed new auditors for the financial year ending March 31, 2027. The remuneration for the Cost Auditor requires ratification by shareholders as an ordinary resolution.

Name Qualification Membership Number Role Term
Keshav Madaan CA 547896 Internal Auditor FY27
M/s Verma Khushwinder & Co. N/A FRN: 000469 Cost Auditor FY27

The cost audit remuneration is fixed at ₹45,000 plus applicable taxes.

AGM and E-Voting Details

The Annual General Meeting will be held on Monday, September 28, 2026, at 11:00 am. The venue is the registered office located at Momnabad Road, Village Akbarpura, Ahmedgarh, Sangrur, Punjab.

Central Depository Services (India) Limited (CDSL) will provide the e-voting facility. The voting period begins on September 25, 2026, at 9:00 am and ends on September 27, 2026, at 5:00 pm.

Historical Stock Returns for Ritesh International

1 Day5 Days1 Month6 Months1 Year5 Years
-0.01%-1.52%+14.06%+59.97%+73.67%+197.80%

How might the acknowledged drop in margins and demand slowdown in FY26 impact Ritesh International's ability to sustain the proposed salary increments for its directors?

What strategic initiatives is management planning to implement to reverse the demand slowdown and improve profitability ahead of the new auditor appointments for FY27?

Could the re-appointment of Mr. Ritesh Arora as Managing Director signal any upcoming changes in corporate governance or operational strategy for the next five years?

Ritesh International expands capacity by 50% with ₹7 crore capex

scanx
Reviewed by
Riya DScanX News Team
Key Highlights

Ritesh International Limited is expanding its Ahmedgarh manufacturing facility by 50%, raising daily output from 80 to 120 metric tons. The ₹7 crore investment is primarily funded by internal accruals (₹6 crore) with minimal bank debt (₹1 crore). Commercial production is targeted for Q1 FY27-28, aiming to capitalize on high utilization rates and growing demand for stearic acid and related products.

powered bylight_fuzz_icon
48497107

*this image is generated using AI for illustrative purposes only.

Ritesh International has approved a 50% expansion of its manufacturing capacity at its Ahmedgarh facility to address rising demand for stearic acid, fatty acid, and glycerin. The company plans to increase its daily production capability from 80 metric tons to 120 metric tons, with commercial operations expected to begin in Q1 FY27-28.

The expansion involves a total capital expenditure of ₹7 crore. Financing will be structured through a mix of long-term bank loans amounting to approximately ₹1 crore and internal accruals covering the balance of ₹6 crore. The project is scheduled for completion within approximately eight months.

Strategic Implications

Ritesh Arora, Chairman and Managing Director, stated that existing facilities are operating near peak capacity utilization. The expansion aims to strengthen market share and enhance operating margins by meeting surging customer demand across core markets. The company emphasized that leveraging debt financing alongside internal accruals allows it to maintain a healthy balance sheet while positioning for sustained revenue growth.

What the Numbers Show

The funding structure reveals a strong reliance on internal resources, with internal accruals accounting for approximately 86% of the total ₹7 crore capital expenditure. This suggests limited incremental leverage pressure on the balance sheet, as only ₹1 crore is being raised through external long-term bank debt. This capital-light approach to expansion indicates the company’s current cash generation capabilities are sufficient to support significant capacity additions without heavily diluting equity or increasing interest burden proportionately.

Project Metric Details
Capacity Increase 50% (from 80 to 120 metric tons/day)
Total Capex ₹7 crore
Funding Source ₹6 crore internal accruals, ₹1 crore bank debt
Timeline Approx. 8 months
Commercial Start Q1 FY27-28

The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Rijul Arora, CFO and Wholetime Director, signed the intimation on August 17, 2026.

Historical Stock Returns for Ritesh International

1 Day5 Days1 Month6 Months1 Year5 Years
-0.01%-1.52%+14.06%+59.97%+73.67%+197.80%

How will the 50% capacity expansion impact Ritesh International's operating margins given the current pricing trends for stearic acid and glycerin in FY27-28?

What is the company's strategy to maintain its near-peak capacity utilization rates once the new 120 metric tons/day production capability comes online?

Could the reliance on internal accruals for 86% of the capex limit Ritesh International's ability to pursue larger strategic acquisitions or diversification projects in the near term?

More News on Ritesh International

1 Year Returns:+73.67%